![Paul Sauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Sauer
Corporate Officer/Principal bei
VAXCYTE, INC.
Profil
Paul W.
Sauer is Senior VP-Process Development & Manufacturing at Vaxcyte, Inc. since 2016.
Former roles include Senior Director-Process Development at Mereo BioPharma 5, Inc. from 2006 to 2011, Vice President-Process Sciences & Manufacturing at Igenica Biotherapeutics, Inc. from 2011 to 2014, Associate Scientist-Cell Culture Development Group at Protein Design Labs, Inc. in 2005, Principal at Genentech, Inc., and Senior Research Associate-Purification at Scios, Inc. Education includes an MBA from Santa Clara University and undergraduate studies at the University of California, Davis.
Aktive Positionen von Paul Sauer
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXCYTE, INC. | Corporate Officer/Principal | 01.04.2016 |
Ehemalige bekannte Positionen von Paul Sauer
| Unternehmen | Position | Ende |
|---|---|---|
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Corporate Officer/Principal | 01.12.2014 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2011 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 01.01.2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Corporate Officer/Principal | - |
Ausbildung von Paul Sauer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
